HIMACS (4299) Q1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2024 earnings summary
16 Oct, 2026Executive summary
Q1 FY2024 revenue fell 2.3% YoY to ¥4,335 million as delayed project launches weighed on sales; operating income declined 29.1% to ¥285 million.
Gross margin held at 20.5%, while higher SG&A, including personnel and training costs, pressured profit.
Financial highlights
Revenue was ¥4,335 million, down ¥102 million or 2.3% YoY; gross profit was ¥887 million, down 2.5%.
Operating income was ¥285 million, down 29.1%; ordinary income was ¥287 million, down 29.0%; quarterly net income was ¥196 million, down 29.0%.
SG&A rose 18.5% to ¥602 million, including higher employee compensation and increased new-hire payroll and training expenses.
Operating income declined by ¥117 million: lower gross profit (-¥23 million), outsourcing-rate increases (-¥21 million), new-hire costs (-¥37 million), and capability-building expenses (-¥58 million) were partly offset by productivity gains (+¥22 million).
Outlook and guidance
FY2024 revenue guidance remained ¥18,150 million, +4.7% YoY; revised operating income to ¥1,680 million, ordinary income to ¥1,690 million, and net income to ¥1,150 million.
Full-year profit forecasts were raised by ¥100 million for operating income, ¥105 million for ordinary income, and ¥70 million for net income; revised EPS is ¥98.69.
Revised Q2 cumulative guidance: revenue ¥8,840 million, operating income ¥660 million, ordinary income ¥665 million, net income ¥455 million, and EPS ¥39.07.
The outlook reflects a certain level of visibility on productivity improvements and better pricing; actual results may vary materially due to multiple factors.
Latest events from HIMACS
- H1 revenue grew, while profit fell; FY guidance remains unchanged.4299
Q2 2027 - Financial DX growth lifted FY2025 results; FY2026 guidance pairs sales growth with nearly flat operating profit.4299
Q4 2024 - Q1 revenue was nearly flat, profits rose, and backlog grew 15.3% YoY.4299
Q1 2025 - H1 profit rose 14.3% as DX backlog grew 29.8%; FY sales guidance was +7.2%.4299
Q2 2025 - DX demand drove FY2025 growth; FY2026 sales are forecast higher as margins ease.4299
Q4 2025 - Profit growth and a 25.0% backlog increase support maintained FY2025 guidance.4299
Q3 2025 - Q1 sales rose 2.9% on end-user and DX demand, while operating profit fell 22%.4299
Q1 2026 - Sales rose 1.5%, but higher costs drove a 15.2% decline in H1 operating profit.4299
Q2 2026 - Revenue edged up, but costs cut profit as an AI- and investment-led growth phase begins.4299
Q4 2026